GlassScriptPhysician profile
Briggs Joyce Geier
NPI 1629230800
$1,641.64
in general payments reported to CMS, 2019-2025
23 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $118 · 2021: $330 · 2022: $187 · 2023: $387 · 2024: $230 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.88 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.65 | 2019-2023 | |
| Hologic Sales and Service, LLC | $172.47 | 2020-2025 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $114.06 | 2023 | Myrisk |
| Myovant Sciences INC. | $99.90 | 2021 | |
| Astellas Pharma US INC | $99.49 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $90.75 | 2021-2024 | Paragard T 380a |
| Organon LLC | $69.67 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $58.71 | 2019-2020 | |
| Baxter Healthcare | $47.57 | 2024 | Perclot |
| Pfizer INC. | $42.45 | 2024-2025 | |
| Minerva Surgical, INC | $42.31 | 2019-2023 | |
| Therapeuticsmd, INC. | $40.53 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $35.13 | 2023 | |
| Lupin INC. | $33.90 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $28.24 | 2023 | |
| Covidien LP | $27.64 | 2019 | |
| Aspira Women'S Health INC | $23.37 | 2024 | Ova1 |
| Medtronic, INC. | $21.93 | 2021 | |
| Daiichi Sankyo INC. | $21.45 | 2022 | |
| Exeltis, USA INC. | $18.22 | 2023 | Slynd |
| Evofem Biosciences, INC. | $16.16 | 2022 | |
| Avion Pharmaceuticals | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Briggs Geier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.